Industry Worries New Medicare Board Will Be Too Isolated
Industry worries the planned Independent Payment Advisory Board, established by the health care reform law to control Medicare spending, will be too insulated from stakeholders to make appropriate policy recommendations.
More from Archive
More from Medtech Insight
The US FDA has approved the Teal Wand, the first at-home cervical cancer screening device. Capable of detecting preclinical cancer with 96% accuracy, it will launch in California in June and expand nationwide soon after.
SS Innovations announced plans to file a de novo application with the US FDA for its SSi Mantra 3 surgical robot, already approved for marketing in six countries. The Florida-based firm also plans to pursue the CE mark for European commercialization.
While MedTech Europe sharpens its focus on what the EU most urgently needs to advance the medtech market in four targeted measures, the European Commission has also unveiled four priorities for 2025.